Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Tirzepatide is studied as a dual-incretin research peptide in models where GLP-1 and GIP receptor pathways are evaluated together, making it relevant to modern metabolic research involving receptor cross-talk, glucose-associated signaling, appetite-associated pathway biology, adipose signaling, and energy-balance regulation
Muscle loss is another concern with weight loss, so patients are advised to include protein-rich foods and muscle-strengthening activities in their routines
Patients should also review and minimise use of non-steroidal anti-inflammatory drugs (NSAIDs) where possible, as these can worsen dyspepsia and reflux
Long-term use may induce side effects such as cardiac arrhythmias or bone loss
Mechanism of Action Comparison# Survodutide# Survodutide (BI 456906) is a dual glucagon/GLP-1 receptor agonist with a molecular weight of 4170.6 Da
US$ 28.97
US$ 21.12
US$ 28.66
US$ 21.26
